NASDAQ$ANGO
AngioDynamics Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
AngioDynamics' second quarter results for fiscal year 2024, which ended November 30, 2023, were announced, with net sales increasing by 2.7% and the company initiating a restructuring of its manufacturing footprint.
AngioDynamics reported a 2.7% increase in net sales to $79.1 million for Q2 2024 on a pro forma basis. The company is undergoing a strategic transformation, including restructuring its manufacturing and optimizing its portfolio, expecting adjusted EPS profitability in FY27.
- Net sales increased by 2.7% on a pro-forma basis compared to the prior-year quarter.
- Med Tech net sales increased 3.5%, while Med Device net sales increased 2.3% on a pro-forma basis.
- GAAP loss per share was $0.72, and adjusted loss per share was $0.05.
- Cash and cash equivalents totaled $60.9 million as of November 30, 2023.
Headline financials
Revenue & EPS history
AngioDynamics · Revenue · Quarterly
$79.1M
Revenue by segment
AngioDynamics · $78.7M total across 2 segments · Q1 2024
- Med Device$52.8M-10.0%67.1%
- Med Tech$25.9M+13.4%32.9%
Forward guidance
AngioDynamics expects fiscal year 2024 net sales to be in the range of $320 to $325 million, gross margin to be approximately 49% to 51%, and adjusted loss per share in the range of $0.35 to $0.42.
Headwinds
- Softer Thrombectomy sales are expected to continue throughout the back half of the year.
- SKU rationalization impacts sales.
- Manufacturing restructuring impacts sales.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2024
-0.9%
Avg return
Earnings day
-2.4%
Avg return
5 days after
-3.7%
Avg return
30 days after
43%
28 / 65 earnings
Positive
+30.9%
Q2 2025
Best reaction
-26.2%
Q1 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +5.0% | -5.0% | — | |
| Q2 2026 | -13.5% | -25.5% | -24.0% | |
| Q1 2026 | +6.1% | -0.2% | +8.7% | |
| Q4 2025 | -10.2% | -9.8% | -9.3% | |
| Q3 2025 | +12.4% | -3.6% | -3.8% | |
| Q2 2025 | +30.9% | +32.6% | +17.4% | |
| Q1 2025 | -20.3% | -23.1% | -12.7% | |
| Q4 2024 | +24.8% | +21.1% | +25.8% | |
| Q3 2024 | +15.6% | +14.6% | +3.1% | |
| Q2 2024 | -17.7% | -20.1% | -23.5% | |
| Q1 2024 | -5.9% | -7.2% | -10.4% | |
| Q4 2023 | -2.5% | -3.8% | -16.1% | |
| Q3 2023 | -17.1% | -23.3% | -33.3% | |
| Q2 2023 | +11.5% | -1.0% | -1.3% | |
| Q1 2023 | -26.2% | -38.0% | -34.8% | |
| Q4 2022 | +4.4% | +6.4% | +21.3% | |
| Q3 2022 | +9.8% | +7.2% | -8.7% | |
| Q2 2022 | -15.5% | -15.5% | -25.8% | |
| Q1 2022 | +12.6% | +17.8% | +22.4% | |
| Q4 2021 | -7.0% | -8.6% | -3.9% | |
| Q3 2021 | +12.3% | +11.1% | +16.3% | |
| Q2 2021 | +14.7% | +14.2% | +24.7% | |
| Q1 2021 | +13.0% | +7.8% | -0.1% | |
| Q4 2020 | -11.5% | -11.8% | -12.7% | |
| Q3 2020 | -2.7% | +2.3% | -0.6% | |
| Q2 2020 | -9.2% | -11.3% | -17.0% | |
| Q1 2020 | -17.6% | -17.6% | -13.7% | |
| Q4 2019 | +6.8% | +6.2% | -4.8% | |
| Q3 2019 | -7.7% | -8.2% | -18.4% | |
| Q2 2019 | +6.7% | +6.7% | +8.6% | |
| Q1 2019 | -10.3% | -12.9% | -17.0% | |
| Q4 2018 | -9.2% | -7.8% | -5.4% | |
| Q3 2018 | +3.2% | +8.9% | +16.4% | |
| Q2 2018 | -1.8% | -0.1% | +5.1% | |
| Q1 2018 | -8.9% | -9.1% | -8.4% | |
| Q4 2017 | -5.9% | -3.5% | +5.1% | |
| Q3 2017 | +0.3% | -1.3% | -10.2% | |
| Q2 2017 | +1.7% | +3.2% | -2.5% | |
| Q1 2017 | -4.5% | -0.1% | -8.4% | |
| Q4 2016 | +10.6% | +14.1% | +8.4% | |
| Q3 2016 | -2.1% | — | — | |
| Q2 2016 | -8.7% | — | — | |
| Q1 2016 | -8.8% | — | — | |
| Q4 2015 | -2.3% | — | — | |
| Q3 2015 | -6.1% | — | — | |
| Q2 2015 | -0.9% | — | — | |
| Q1 2015 | +3.8% | — | — | |
| Q4 2014 | -5.0% | — | — | |
| Q3 2014 | -1.5% | — | — | |
| Q2 2014 | +6.1% | — | — | |
| Q1 2014 | +5.3% | — | — | |
| Q4 2013 | +1.3% | — | — | |
| Q3 2013 | -7.4% | — | — | |
| Q2 2013 | -2.4% | — | — | |
| Q1 2013 | -8.8% | — | — | |
| Q4 2010 | -0.9% | — | — | |
| Q4 2012 | +4.0% | — | — | |
| Q3 2011 | -1.3% | — | — | |
| Q3 2012 | -1.3% | — | — | |
| Q2 2012 | -5.7% | — | — | |
| Q2 2011 | -5.7% | — | — | |
| Q1 2011 | +3.5% | — | — | |
| Q4 2011 | +3.5% | — | — | |
| Q1 2012 | +3.5% | — | — | |
| Q3 2010 | +0.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro